Waldenström’s Macroglobulinemia (Post nr. 8624)
[ visa ren ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04564nam a22004815i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 59934 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20200226102636.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 161006s2017 gw | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783319225845 |
| -- | 978-3-319-22584-5 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-3-319-22584-5 |
| Source of number or code | doi |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (DE-He213)978-3-319-22584-5 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RB45 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MJF |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED038000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.15 |
| Edition number | 23 |
| 245 10 - TITLE STATEMENT | |
| Title | Waldenström’s Macroglobulinemia |
| Medium | [electronic resource] / |
| Statement of responsibility, etc. | edited by Véronique Leblond, Steve Treon, Meletios Dimoploulos. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Cham : |
| Name of producer, publisher, distributor, manufacturer | Springer International Publishing : |
| -- | Imprint: Springer, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2017. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | IX, 377 p. 28 illus., 15 illus. in color. |
| Other physical details | online resource. |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS | |
| File type | text file |
| Encoding format | |
| Source | rda |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Preface: Tribute to J Waldenström -- Part I: Tumor Cells and microenvironment -- Waldenström Macroglobulinaemia: Pathological Features and Diagnostic Assessment -- Waldenström’s Macroglobulinemia Immunophenotype -- Predispositions and Origins of Waldenstrom Macroglobulinemia: Implications from Genetic Analysis -- Cytogenetics in Waldenstr<öm Macroglobulinemia (WM) -- Genetic and Signaling Abnormalities in Waldenström’s Macroglobulinemia -- Molecular Pathways in Growth and Survival: Epigenomics -- The Bone Marrow Microenvironment and Tumor Cells Interactions in Waldenström’s Macroglobulinemia -- Waldenström’s Macroglobulinaemia: Immunosurveillance and the Immune Micro-environment -- Part II: Epidemiology and Genetic Predisposition -- Epidemiology of Waldenström Macroglobulinemia -- Genetic Predisposition to Waldenström Macroglobulinemia -- Immunoglobulin Type M Monoclonal Gammopathy of Undetermined Significance (IgM-MGUS) -- Part III: Clinical Features -- Hyperviscosity Syndrome, Cold Agglutinin Hemolytic Anemia, and Cryoglobulinemia -- Neuropathy in Waldenström’s Macroglobulinaemia -- IgM Amyloidosis -- The Bing-Neel Syndrome -- Unusual Manifestations of IgM Monoclonal Gammopathies -- Part IV: Laboratory Investigations -- Laboratory Investigations and Findings: Hematological Abnormalities, Biochemical Investigations, Free Light and Heavy Chains -- Part V: Response -- Response Assessment in Waldenström’s Macroglobulinaemia -- Part VI: Prognostic Factors -- Risk Stratification in Waldenström Macroglobulinemia -- Part VII: Treatment Options and Recommendations -- Indications for Treatment of Waldenström’s Macroglobulinemia -- Immunotherapy in Waldenström’s Macroglobulinemia -- Immunomodulatory Agents and Proteasome Inhibitors in Waldenström’s Macroglobulinemia -- Signal Inhibitors in Waldenström’s Macroglobulinemia -- High-Dose Therapy and Haemopoietic Stem Cell Transplantation in Waldenström’s Macroglobulinaemia -- Long-Term Toxicity of Therapy in Waldenström Macroglobulinemia -- Treatment Recommendations in Waldenström Macroglobulinemia. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This book sheds new light on clinical, biological and therapeutic data on the rare disease Waldenström’s Macroglobulinemia (WM) with the participation of widely-recognized experts, involved in this field. It represents the efforts of physicians, scientists and patients, all around the world, to better understand and cure this rare disease. Considerable advances in the diagnosis, treatment indications, response criteria, prognostic factors and treatment options have been made since Dr Jan Waldenström first reported this “new syndrome“ 70 years ago. Particularly instrumental in advancing of our understanding of WM have been the eight international workshops devoted to this disease. New, exciting molecular data have recently been reported, allowing us to revisit the oncogenic events leading to WM B-cell proliferation and to use newly available compounds targeting oncogenic pathways. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hematology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neurology. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Medicine & Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hematology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neurology. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Leblond, Véronique. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Treon, Steve. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dimoploulos, Meletios. |
| Relator term | editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed edition: |
| International Standard Book Number | 9783319225838 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://dx.doi.org/10.1007/978-3-319-22584-5">http://dx.doi.org/10.1007/978-3-319-22584-5</a> |
| 912 ## - | |
| -- | ZDB-2-SME |
Inga exemplar finns tillgängliga.